• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Mar8
Allovir released FY2024 Q4 earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -3.636 USD (forecast -1.15 USD)
04:00
Allovir released FY2024 annual earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -11.7339 USD (forecast -15.6399 USD)
04:00
Mar3
Halper Sadeh LLC's Investigation into AlloVir, Inc.'s Merger
18:57
Nov13
Allovir released FY2024 9 Months Earnings on November 12 (EST) with actual revenue of 0 USD and EPS of -8.1123 USD
04:00
Allovir released FY2024 Q3 earnings on November 12 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -0.8223 USD (forecast -1.15 USD)
04:00
Nov12
AlloVir Acquires Kalaris Therapeutics to Form New Entity
00:46

Schedules & Filings

Schedules
Filings
Mar19
Ticker Change(EST)

From 03.19 changed to KLRS

Mar7
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -18.27 M, EPS -3.636

Jan16
Reverse Stock Split(EST)

1-for-23 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More